{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:24:32Z","timestamp":1789932272628,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T00:00:00Z","timestamp":1498521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Direction g\u00e9n\u00e9rale de la sant\u00e9","award":["PHRC-12-024-0278"],"award-info":[{"award-number":["PHRC-12-024-0278"]}]},{"name":"Janssen Pharmaceutical Companies","award":["PHRC-12-024-0278"],"award-info":[{"award-number":["PHRC-12-024-0278"]}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["PHRC-12-024-0278"],"award-info":[{"award-number":["PHRC-12-024-0278"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00127-017-1411-z","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T12:56:16Z","timestamp":1498568176000},"page":"1113-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience"],"prefix":"10.1007","volume":"52","author":[{"name":"French Housing First Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tinland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zemmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Auquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boucekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Loubi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,27]]},"reference":[{"key":"1411_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw136","author":"SN Rezansoff","year":"2016","unstructured":"Rezansoff SN, Moniruzzaman A, Fazel S, McCandless L, Procyshyn R, Somers JM (2016) Housing first improves adherence to antipsychotic medication among formerly homeless adults with schizophrenia: results of a randomized controlled trial. Schizophr Bull. doi: 10.1093\/schbul\/sbw136","journal-title":"Schizophr Bull"},{"issue":"9953","key":"1411_CR2","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0140-6736(14)61132-6","volume":"384","author":"S Fazel","year":"2014","unstructured":"Fazel S, Geddes JR, Kushel M (2014) The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations. Lancet 384(9953):1529\u20131540. doi: 10.1016\/S0140-6736(14)61132-6","journal-title":"Lancet"},{"issue":"6","key":"1411_CR3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1034\/j.1600-0447.2002.02209.x","volume":"105","author":"D Folsom","year":"2002","unstructured":"Folsom D, Jeste DV (2002) Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr Scand 105(6):404\u2013413","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"1411_CR4","doi-asserted-by":"publisher","first-page":"e79677","DOI":"10.1371\/journal.pone.0079677","volume":"8","author":"P Auquier","year":"2013","unstructured":"Auquier P, Tinland A, Fortanier C, Loundou A, Baumstarck K, Lancon C, Boyer L (2013) Toward meeting the needs of homeless people with schizophrenia: the validity of quality of life measurement. PLoS One 8(10):e79677. doi: 10.1371\/journal.pone.0079677","journal-title":"PLoS One"},{"issue":"12","key":"1411_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00127-016-1259-7","volume":"51","author":"SN Rezansoff","year":"2016","unstructured":"Rezansoff SN, Moniruzzaman A, Fazel S, Procyshyn R, Somers JM (2016) Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study. Soc Psychiatry Psychiatr Epidemiol 51(12):1623\u20131632. doi: 10.1007\/s00127-016-1259-7","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"3","key":"1411_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4088\/JCP.v67n0317","volume":"67","author":"H Ascher-Svanum","year":"2006","unstructured":"Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW (2006) Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 67(3):453\u2013460","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"1411_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","volume":"161","author":"TP Gilmer","year":"2004","unstructured":"Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV (2004) Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. Am J Psychiatry 161(4):692\u2013699. doi: 10.1176\/appi.ajp.161.4.692","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"1411_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","volume":"176","author":"D Novick","year":"2010","unstructured":"Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM (2010) Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res 176(2\u20133):109\u2013113. doi: 10.1016\/j.psychres.2009.05.004","journal-title":"Psychiatry Res"},{"issue":"12","key":"1411_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4088\/JCP.12m08331","volume":"74","author":"M Sajatovic","year":"2013","unstructured":"Sajatovic M, Levin J, Ramirez LF, Hahn DY, Tatsuoka C, Bialko CS, Cassidy KA, Fuentes-Casiano E, Williams TD (2013) Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. J Clin Psychiatry 74(12):1249\u20131255. doi: 10.4088\/JCP.12m08331","journal-title":"J Clin Psychiatry"},{"key":"1411_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1472-6963-12-155","volume":"12","author":"WM Vollmer","year":"2012","unstructured":"Vollmer WM, Xu M, Feldstein A, Smith D, Waterbury A, Rand C (2012) Comparison of pharmacy-based measures of medication adherence. BMC Health Serv Res 12:155. doi: 10.1186\/1472-6963-12-155","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"1411_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","volume":"5","author":"MJ Stirratt","year":"2015","unstructured":"Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, Aikens JE, Hunter CM, Velligan DI, Huntley K, Ogedegbe G, Rand CS, Schron E, Nilsen WJ (2015) Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med 5(4):470\u2013482. doi: 10.1007\/s13142-015-0315-2","journal-title":"Transl Behav Med"},{"key":"1411_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12888-016-0758-0","volume":"16","author":"JM Somers","year":"2016","unstructured":"Somers JM, Moniruzzaman A, Currie L, Rezansoff SN, Russolillo A, Parpouchi M (2016) Accuracy of reported service use in a cohort of people who are chronically homeless and seriously mentally ill. BMC Psychiatry 16:41. doi: 10.1186\/s12888-016-0758-0","journal-title":"BMC Psychiatry"},{"key":"1411_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.10.023","author":"G Fond","year":"2016","unstructured":"Fond G, Boyer L, Boucekine M, Aden LA, Schurhoff F, Tessier A, Andrianarisoa M, Berna F, Brunel L, Capdevielle D, Chereau I, Mallet J, Denizot H, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Rey R, Richieri R, Passerieux C, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Misdrahi D, group F-S (2016) Validation study of the Medication Adherence Rating Scale Results from the FACE-SZ national dataset. Schizophr Res. doi: 10.1016\/j.schres.2016.10.023","journal-title":"Schizophr Res"},{"key":"1411_CR14","doi-asserted-by":"publisher","first-page":"31598","DOI":"10.1038\/srep31598","volume":"6","author":"K Zemmour","year":"2016","unstructured":"Zemmour K, Tinland A, Boucekine M, Girard V, Loubiere S, Resseguier N, Fond G, Auquier P, Boyer L, French Housing First Study G (2016) Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: results from the French Housing First experience. Sci Rep 6:31598. doi: 10.1038\/srep31598","journal-title":"Sci Rep"},{"key":"1411_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/1745-6215-14-309","volume":"14","author":"A Tinland","year":"2013","unstructured":"Tinland A, Fortanier C, Girard V, Laval C, Videau B, Rhenter P, Greacen T, Falissard B, Apostolidis T, Lancon C, Boyer L, Auquier P (2013) Evaluation of the Housing First program in patients with severe mental disorders in France: study protocol for a randomized controlled trial. Trials 14:309. doi: 10.1186\/1745-6215-14-309","journal-title":"Trials"},{"key":"1411_CR16","volume-title":"Diagnostic and statistical manual of mental disorders. Text revised","author":"A Ap","year":"2000","unstructured":"Ap A (2000) Diagnostic and statistical manual of mental disorders. Text revised, 4th edn. American Psychiatric Association, Washington, DC","edition":"4"},{"key":"1411_CR17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/bsl.707","volume":"24","author":"DV Jeste","year":"2006","unstructured":"Jeste DV, Saks E (2006) Decisional capacity in mental illness and substance use disorders: empirical database and policy implications. Behav Sci Law 24:607\u2013628","journal-title":"Behav Sci Law"},{"issue":"5","key":"1411_CR18","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.lpm.2011.09.032","volume":"41","author":"V Girard","year":"2012","unstructured":"Girard V, Sarradon-Eck A, Payan N, Bonin JP, Perrot S, Vialars V, Boyer L, Tinland A, Simeoni MC (2012) The analysis of a mobile mental health outreach team activity: from psychiatric emergencies on the street to practice of hospitalization at home for homeless people. Presse Med 41(5):e226\u2013e237. doi: 10.1016\/j.lpm.2011.09.032","journal-title":"Presse Med"},{"issue":"3","key":"1411_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1011571531303","volume":"3","author":"KJ Conrad","year":"2001","unstructured":"Conrad KJ, Yagelka JR, Matters MD, Rich AR, Williams V, Buchanan M (2001) Reliability and validity of a modified Colorado Symptom Index in a national homeless sample. Ment Health Serv Res 3(3):141\u2013153","journal-title":"Ment Health Serv Res"},{"issue":"4","key":"1411_CR20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02207489","volume":"30","author":"S Barker","year":"1994","unstructured":"Barker S, Barron N, McFarland BH, Bigelow DA (1994) A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity. Community Ment Health J 30(4):363\u2013383","journal-title":"Community Ment Health J"},{"issue":"5","key":"1411_CR21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF02189063","volume":"30","author":"S Barker","year":"1994","unstructured":"Barker S, Barron N, McFarland BH, Bigelow DA, Carnahan T (1994) A community ability scale for chronically mentally ill consumers: Part II. Applications. Community Ment Health J 30(5):459\u2013472","journal-title":"Community Ment Health J"},{"issue":"Suppl 20","key":"1411_CR22","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22\u201333","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1411_CR23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II. Addiction 88(6):791\u2013804","journal-title":"Addiction"},{"issue":"9","key":"1411_CR24","doi-asserted-by":"publisher","first-page":"e1130","DOI":"10.4088\/JCP.15m10115","volume":"77","author":"D Misdrahi","year":"2016","unstructured":"Misdrahi D, Tessier A, Swendsen J, Berna F, Brunel L, Capdevielle D, Chereau I, Danion JM, De Pradier M, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Rey R, Richieri R, Passerieux C, Schandrin A, Schurhoff F, Tronche AM, Urbach M, Llorca PM, Fond G, Group F-S (2016) Determination of adherence profiles in schizophrenia using self-reported adherence: results from the FACE-SZ dataset. J Clin Psychiatry 77(9):e1130\u2013e1136. doi: 10.4088\/JCP.15m10115","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"1411_CR25","doi-asserted-by":"publisher","first-page":"e47655","DOI":"10.1371\/journal.pone.0047655","volume":"7","author":"L Boyer","year":"2012","unstructured":"Boyer L, Cermolacce M, Dassa D, Fernandez J, Boucekine M, Richieri R, Vaillant F, Dumas R, Auquier P, Lancon C (2012) Neurocognition, insight and medication nonadherence in schizophrenia: a structural equation modeling approach. PLoS One 7(10):e47655. doi: 10.1371\/journal.pone.0047655","journal-title":"PLoS One"},{"issue":"10","key":"1411_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3109\/00048674.2010.493503","volume":"44","author":"D Dassa","year":"2010","unstructured":"Dassa D, Boyer L, Benoit M, Bourcet S, Raymondet P, Bottai T (2010) Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Aust N Z J Psychiatry 44(10):921\u2013928. doi: 10.3109\/00048674.2010.493503","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"1411_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.psc.2016.04.001","volume":"39","author":"JF Goldberg","year":"2016","unstructured":"Goldberg JF, Ernst CL (2016) Core concepts involving adverse psychotropic drug effects: assessment, implications, and management. Psychiatr Clin North Am 39(3):375\u2013389. doi: 10.1016\/j.psc.2016.04.001","journal-title":"Psychiatr Clin North Am"},{"issue":"2","key":"1411_CR28","first-page":"55","volume":"11","author":"I Ofotokun","year":"2003","unstructured":"Ofotokun I, Pomeroy C (2003) Sex differences in adverse reactions to antiretroviral drugs. Top HIV Med 11(2):55\u201359","journal-title":"Top HIV Med"},{"issue":"2","key":"1411_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2125.2003.01865.x","volume":"56","author":"H El-Eraky","year":"2003","unstructured":"El-Eraky H, Thomas SH (2003) Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine. Br J Clin Pharmacol 56(2):198\u2013204","journal-title":"Br J Clin Pharmacol"},{"issue":"1055","key":"1411_CR30","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/postgradmedj-2012-131730","volume":"89","author":"K Faasse","year":"2013","unstructured":"Faasse K, Petrie KJ (2013) The nocebo effect: patient expectations and medication side effects. Postgrad Med J 89(1055):540\u2013546. doi: 10.1136\/postgradmedj-2012-131730","journal-title":"Postgrad Med J"},{"issue":"1","key":"1411_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02673038608720559","volume":"1","author":"S Watson","year":"1986","unstructured":"Watson S (1986) Women and housing or feminist housing analysis? Hous Stud 1(1):1\u201310","journal-title":"Hous Stud"},{"key":"1411_CR32","unstructured":"Whitzman C (2010) Making the invisible visible: Canadian women, homelessness, and health outside the \u201cbig city\u201d. In: Finding home: policy options for addressing homelessness in Canada. http:\/\/homelesshub.ca\/sites\/default\/files\/4.3%20Whitzman%20Homelessness%20Outside%20the%20Big%20City.pdf . Accessed 5 Jan 2017"},{"key":"1411_CR33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1525\/9780520918573","volume-title":"Making the invisible visible: a multicultural planning history","author":"L Sandercock","year":"1998","unstructured":"Sandercock L (1998) Making the invisible visible: a multicultural planning history. University of California Press, California, p 294"},{"issue":"1","key":"1411_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/02673039708720882","volume":"12","author":"J Neale","year":"1997","unstructured":"Neale J (1997) Homelessness and theory reconsidered. Hous Stud 12(1):47\u201361","journal-title":"Hous Stud"},{"key":"1411_CR35","doi-asserted-by":"crossref","unstructured":"Tinland A, Boyer L, Loubi\u00e8re S, Greacen T, Girard V, Boucekine M, Fond G, Auquier P, Group FHFS (2017) Breaking women\u2019s glass ceiling: violent victimization and post-traumatic stress disorder in homeless women with severe mental illnesses are associated with depression, suicide risk, impaired quality of life and impaired physical health. Results from the multisite French Housing First Study. Submitted","DOI":"10.2147\/NDT.S161377"},{"issue":"1\u20133","key":"1411_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.schres.2016.03.026","volume":"174","author":"CL Hui","year":"2016","unstructured":"Hui CL, Poon VW, Ko WT, Miao HY, Chang WC, Lee EH, Chan SK, Lin J, Chen EY (2016) Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis. Schizophr Res 174(1\u20133):144\u2013149. doi: 10.1016\/j.schres.2016.03.026","journal-title":"Schizophr Res"},{"issue":"3","key":"1411_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/erp.13.15","volume":"13","author":"L Boyer","year":"2013","unstructured":"Boyer L, Baumstarck K, Boucekine M, Blanc J, Lancon C, Auquier P (2013) Measuring quality of life in patients with schizophrenia: an overview. Expert Rev Pharmacoecon Outcomes Res 13(3):343\u2013349. doi: 10.1586\/erp.13.15","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1411_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/PPA.S124658","volume":"11","author":"DI Velligan","year":"2017","unstructured":"Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP (2017) Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence 11:449\u2013468. doi: 10.2147\/PPA.S124658","journal-title":"Patient Prefer Adherence"},{"issue":"1\u20132","key":"1411_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.psychres.2015.06.033","volume":"229","author":"A Caqueo-Urizar","year":"2015","unstructured":"Caqueo-Urizar A, Boyer L, Baumstarck K, Gilman SE (2015) The relationships between patients\u2019 and caregivers\u2019 beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries. Psychiatry Res 229(1\u20132):440\u2013446. doi: 10.1016\/j.psychres.2015.06.033","journal-title":"Psychiatry Res"},{"issue":"1","key":"1411_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0447.2012.01911.x","volume":"127","author":"H Jonsdottir","year":"2013","unstructured":"Jonsdottir H, Opjordsmoen S, Birkenaes AB, Simonsen C, Engh JA, Ringen PA, Vaskinn A, Friis S, Sundet K, Andreassen OA (2013) Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand 127(1):23\u201333. doi: 10.1111\/j.1600-0447.2012.01911.x","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"1411_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/JCP.0000000000000623","volume":"37","author":"HY Chan","year":"2017","unstructured":"Chan HY, Pan YJ, Chen JJ, Chen CH (2017) Time to discontinuation of second-generation antipsychotics versus haloperidol and sulpiride in people with schizophrenia: a naturalistic. Comparative study. J Clin Psychopharmacol 37(1):13\u201320. doi: 10.1097\/JCP.0000000000000623","journal-title":"J Clin Psychopharmacol"},{"issue":"1\u20133","key":"1411_CR42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.schres.2015.10.005","volume":"169","author":"VC Chen","year":"2015","unstructured":"Chen VC, Liao YT, Lai TJ, Lane HY, Shao WC, Dewey M, Lee CT, Lu ML (2015) Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: a nationwide population-based cohort study. Schizophr Res 169(1\u20133):406\u2013411. doi: 10.1016\/j.schres.2015.10.005","journal-title":"Schizophr Res"},{"issue":"3","key":"1411_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/0253-7176.135382","volume":"36","author":"MS Karthik","year":"2014","unstructured":"Karthik MS, Warikoo N, Chakrabarti S, Grover S, Kulhara P (2014) Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications. Indian J Psychol Med 36(3):288\u2013293. doi: 10.4103\/0253-7176.135382","journal-title":"Indian J Psychol Med"},{"issue":"1","key":"1411_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/0253-7176.127244","volume":"36","author":"N Warikoo","year":"2014","unstructured":"Warikoo N, Chakrabarti S, Grover S (2014) Adherence and continuation of treatment with first- and second-generation antipsychotics in schizophrenia. Indian J Psychol Med 36(1):33\u201339. doi: 10.4103\/0253-7176.127244","journal-title":"Indian J Psychol Med"},{"issue":"3","key":"1411_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/15622975.2015.1009163","volume":"16","author":"A Hasan","year":"2015","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller HJ, Schizophrenia WTFoTGf (2015) World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for biological treatment of schizophrenia. Part 3: update 2015 management of special circumstances: depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry 16(3):142\u2013170. doi: 10.3109\/15622975.2015.1009163","journal-title":"World J Biol Psychiatry"},{"issue":"Suppl 1","key":"1411_CR46","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19(Suppl 1):1\u201393","journal-title":"CNS Drugs"},{"issue":"8","key":"1411_CR47","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","volume":"61","author":"A Tschoner","year":"2007","unstructured":"Tschoner A, Engl J, Laimer M, Kaser S, Rettenbacher M, Fleischhacker WW, Patsch JR, Ebenbichler CF (2007) Metabolic side effects of antipsychotic medication. Int J Clin Pract 61(8):1356\u20131370. doi: 10.1111\/j.1742-1241.2007.01416.x","journal-title":"Int J Clin Pract"},{"issue":"1\u20133","key":"1411_CR48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.schres.2012.03.017","volume":"140","author":"J Caemmerer","year":"2012","unstructured":"Caemmerer J, Correll CU, Maayan L (2012) Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res 140(1\u20133):159\u2013168. doi: 10.1016\/j.schres.2012.03.017","journal-title":"Schizophr Res"},{"issue":"2","key":"1411_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/acps.12445","volume":"132","author":"P Manu","year":"2015","unstructured":"Manu P, Dima L, Shulman M, Vancampfort D, De Hert M, Correll CU (2015) Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand 132(2):97\u2013108. doi: 10.1111\/acps.12445","journal-title":"Acta Psychiatr Scand"},{"issue":"1\u20133","key":"1411_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.schres.2007.10.029","volume":"100","author":"L Fialko","year":"2008","unstructured":"Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, Freeman D (2008) A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res 100(1\u20133):53\u201359. doi: 10.1016\/j.schres.2007.10.029","journal-title":"Schizophr Res"},{"issue":"4","key":"1411_CR51","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/schbul\/sbj075","volume":"32","author":"DI Velligan","year":"2006","unstructured":"Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32(4):724\u2013742. doi: 10.1093\/schbul\/sbj075","journal-title":"Schizophr Bull"},{"issue":"3","key":"1411_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/NMD.0000000000000462","volume":"205","author":"AG Maremmani","year":"2017","unstructured":"Maremmani AG, Bacciardi S, Gehring ND, Cambioli L, Schutz C, Jang K, Krausz M (2017) Substance use among homeless individuals with schizophrenia and bipolar disorder. J Nerv Ment Dis 205(3):173\u2013177. doi: 10.1097\/NMD.0000000000000462","journal-title":"J Nerv Ment Dis"},{"issue":"5","key":"1411_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/acps.12722","volume":"135","author":"H Verdoux","year":"2017","unstructured":"Verdoux H, Pambrun E, Tournier M, Bezin J, Pariente A (2017) Risk of discontinuation of\u00a0antipsychotic\u00a0long-acting\u00a0injections\u00a0vs. oral\u00a0antipsychotics\u00a0in real-life prescribing practice: a community-based study. Acta Psychiatr Scand 135(5):429\u2013438. doi: 10.1111\/acps.12722","journal-title":"Acta Psychiatr Scand"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00127-017-1411-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-017-1411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-017-1411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T23:48:51Z","timestamp":1602373731000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00127-017-1411-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,27]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1007\/s00127-017-1411-z","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,27]]}}}